Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Aconcagua Bio, Inc. A Wholly Owned Subsidiary Of Structure Therapeutics

Clinical trials sponsored by Aconcagua Bio, Inc. A Wholly Owned Subsidiary Of Structure Therapeutics, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Oral drug for obesity tested in First-in-Human trial Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Oral drug for obesity tested in First-in-Human trial

Disease control Recruiting now

Researchers are testing a new oral drug called ACCG-2671 to see if it is safe and how the body processes it. The trial includes healthy volunteers and people with obesity, some of whom are already taking a GLP-1 drug for weight loss. Participants will receive either ACCG-2671 or …

Phase 1/2 • Sponsor: Aconcagua Bio, Inc. a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control

Last updated Sep 16, 2026 00:00 UTC